{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:46:07Z","timestamp":1782794767352,"version":"3.54.5"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atrial septal anomalies such as patent foramen ovale (PFO), atrial septal aneurysm (ASA), and lipomatous hypertrophy of the interatrial septum (LHIS) are frequently identified by transoesophageal echocardiography (TEE) in patients undergoing atrial fibrillation (AF) ablation. While ASAs have been linked to arrhythmogenic potential, their influence on post-ablation outcomes, particularly after cryoballoon ablation (CBA), is poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective single-center cohort study we enrolled all patients who underwent CBA-based pulmonary vein isolation (PVI) for paroxysmal or persistent AF between June 2015 and April 2024 at our center and had preprocedural TEE imaging. Interatrial septal morphology\u2014including PFO, ASA, and LHIS\u2014was assessed. The primary endpoint was AF recurrence, defined as any episode lasting &amp;gt;30\u2005s beyond the 90-day blanking period. Kaplan\u2013Meier analysis and Cox proportional hazards modeling were used for time-to-event analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 657 patients (mean age 61.7\u2009\u00b1\u20099.6 years; 71.2% male), PFO was identified in 16.6%, LHIS in 5.7%, and ASA in 1.0%. Over a median follow-up of 19 months (IQR: 3\u201376), AF recurrence occurred in 26.8%. Kaplan\u2013Meier analysis revealed a significantly lower recurrence rate in patients with PFO compared to those without PFO (HR: 0.62; 95% CI: 0.43\u20130.89;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.010). This association was independent from other clinical, electrophysiological and echocardiographic confounders (HR: 0.56; 95% CI: 0.38\u20130.83;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this single-center cohort, the presence of PFO was independently associated with a lower risk of AF recurrence following CBA. These findings suggest a potential protective role of PFO and merit further prospective investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1840929","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:24:29Z","timestamp":1782793469000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Reduced recurrence of atrial fibrillation after cryoballoon ablation in patients with preprocedural patent foramen ovale: a retrospective single-center observational cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Stefano","family":"Bonapace","sequence":"first","affiliation":[{"name":"Department of Cardiology, IRCCS Sacro Cuore \u2013 Don Calabria","place":["Negrar di Valpolicella, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Costa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, IRCCS Sacro Cuore \u2013 Don Calabria","place":["Negrar di Valpolicella, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Marinelli","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AOOR Villa Sofia-Cervello","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lanzoni","sequence":"additional","affiliation":[{"name":"Department of Cardiology, IRCCS Sacro Cuore \u2013 Don Calabria","place":["Negrar di Valpolicella, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Molon","sequence":"additional","affiliation":[{"name":"Department of Cardiology, IRCCS Sacro Cuore \u2013 Don Calabria","place":["Negrar di Valpolicella, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/echo.12067","article-title":"High incidence of echocardiographic abnormalities of the interatrial septum in patients undergoing ablation for atrial fibrillation","volume":"30","author":"Schernthaner","year":"2013","journal-title":"Echocardiography"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e27165","DOI":"10.1097\/md.0000000000027165","article-title":"A meta-analysis of the association of atrial septal abnormalities and atrial vulnerability","volume":"100","author":"Sun","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1161\/01.STR.31.2.398","article-title":"Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause","volume":"31","author":"Berthet","year":"2000","journal-title":"Stroke"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1161\/01.CIR.91.11.2785","article-title":"Atrial septal aneurysm in adult patients: a multicenter study using transthoracic and transesophageal echocardiography","volume":"91","author":"M\u00fcgge","year":"1995","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/S0735-1097(85)80228-X","article-title":"Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases","volume":"6","author":"Hanley","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jcin.2009.05.010","article-title":"Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism?","volume":"2","author":"Rigatelli","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"B7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/0735-1097(93)90839-S","article-title":"Clinical, electrocardiographic and morphologic features of massive fatty deposites (\u201clipomatous hypertrophy\u201d) in the atrial septum","volume":"22","author":"Shirani","year":"1993","journal-title":"JACC"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1378\/chest.124.6.2068","article-title":"Lipomatous hypertrophy of the interatrial septum: a prospective study of incidence, imaging findings, and clinical symptoms","volume":"124","author":"Heyer","year":"2003","journal-title":"Chest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.33963\/kp.a2021.0004","article-title":"Patent foramen ovale and left atrial appendage flow velocity predict atrial fibrillation recurrence post cryoballoon ablation","volume":"79","author":"Kie\u0142basa","year":"2021","journal-title":"Kardiol Pol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ijcard.2019.11.125","article-title":"Patent foramen ovale in patients with atrial fibrillation","volume":"300","author":"Sposato","year":"2020","journal-title":"Int J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.echo.2015.05.015","article-title":"Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: a report from the American Society of Echocardiography","volume":"28","author":"Silvestry","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"euae043","DOI":"10.1093\/europace\/euae043","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"26","author":"Tzeis","year":"2024","journal-title":"Europace"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1161\/01.CIR.99.15.1942","article-title":"Frequency of atrial septal aneurysms in patients with cerebral ischemic events","volume":"99","author":"Agmon","year":"1999","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1016\/j.jaccas.2020.10.007","article-title":"Gaining insights into lipomatous hypertrophy of the interatrial septum: a step forward","volume":"2","author":"Casado-Arroyo","year":"2020","journal-title":"JACC Case Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/S0735-1097(83)80151-X","article-title":"Diagnosis of lipomatous hypertrophy of the atrial septum by two-dimensional echocardiography","volume":"1","author":"Fyke","year":"1983","journal-title":"JACC"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1161\/01.cir.96.5.1686","article-title":"Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated langendorff-perfused rabbit heart","volume":"96","author":"Ravelli","year":"1997","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.hrthm.2022.10.009","article-title":"Reduction in atrial and pulmonary vein stretch as a therapeutic target for prevention of atrial fibrillation","volume":"20","author":"Gottlieb","year":"2023","journal-title":"Heart Rhythm"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-Term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1001\/jama.2021.20956","article-title":"Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke","volume":"326","author":"Kent","year":"2021","journal-title":"JAMA"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e034249","DOI":"10.1161\/JAHA.124.034249","article-title":"Atrial fibrillation after patent foramen ovale closure: incidence, pathophysiology, and management","volume":"13","author":"Apostolos","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.4244\/EIJV10I12A257","article-title":"Very long-term follow-up after percutaneous closure of patent foramen ovale","volume":"10","author":"Eeckhout","year":"2015","journal-title":"EuroIntervention"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.4244\/EIJ-D-25-00603","article-title":"Atrial fibrillation following patent foramen ovale closure: a cohort study with continuous implantable cardiac monitoring","volume":"22","author":"Gautier","year":"2026","journal-title":"EuroIntervention"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3390\/life14121590","article-title":"Arrhythmias following patent foramen ovale closure: an unsolved Enigma","volume":"14","author":"Karanikola","year":"2024","journal-title":"Life"},{"key":"B25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s12016-021-08867-0","article-title":"Nickel hypersensitivity to atrial septal occluders: smoke without fire?","volume":"62","author":"Apostolos","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","article-title":"Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts","volume":"59","author":"Hagen","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1161\/CIRCEP.111.966523","article-title":"Acute pulmonary vein isolation is achieved by a combination of reversible and irreversible atrial injury after catheter ablation: evidence from magnetic resonance imaging","volume":"5","author":"Arujuna","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1536\/ihj.18-413","article-title":"Early tissue reaction after second-generation cryoballoon ablation evaluated with intracardiac echocardiography evidence of acute tissue edema after cryoballoon ablation","volume":"60","author":"Miyazaki","year":"2019","journal-title":"Int Heart J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e005988","DOI":"10.1161\/JAHA.117.005988","article-title":"Acute hemodynamic and tissue effects of cryoballoon ablation on pulmonary vessels: the IVUS-cryo study","volume":"6","author":"Baran","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in olmsted county, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijcard.2019.11.088","article-title":"Patent foramen ovale prevalence in atrial fibrillation patients and its clinical significance; A single center experience","volume":"300","author":"Daher","year":"2020","journal-title":"Int J Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1540-8167.2008.01260.x","article-title":"Impact of a patent foramen ovale on paroxysmal atrial fibrillation ablation","volume":"19","author":"Knecht","year":"2008","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1840929\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:24:30Z","timestamp":1782793470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1840929\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":32,"alternative-id":["10.3389\/fcvm.2026.1840929"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1840929","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"article-number":"1840929"}}